Nutrition21 Launches Nitrosigine™, A Novel Patented Source Of Inositol-Stabilized Arginine Silicate
Nutrition 21, LLC, a leading developer and marketer of nutritional ingredients whose health benefits are substantiated by extensive clinical research, proudly announced today the launch of Nitrosigine™, a novel patented source of inositol-stabilized arginine silicate accepted by the United States Food and Drug Administration (FDA) as a New Dietary Ingredient (NDI). In pre-clinical studies, Nitrosigine™ has been shown to demonstrate superiority over arginine in blood flow markers and has been shown to positively affect silicon absorption, providing evidence of health benefits applicable to many market categories.
Nitrosigine®, Velositol®, nooLVL®, Lustriva™, Chromax®, Zinmax®, and their associated logos are registered trademarks of Nutrition21, LLC. All third party trademarks are the property of their respective owners. Nutrition21, LLC's products are protected by a number of patents including, but not limited to: US Patent Nos. 6,809,115; 6,803,456; 7,576,132; 8,062,677; 8,933,022; 9,005,637; 9,028,879; 9,119,835; 9,421,170; 9,597,404; 9,675,702; 10,183,049; 10,245,325; and 10,363,222.
These statements have not been evaluated by the Food and Drug Administration. These products are not intended to diagnose, treat, cure, or prevent any disease.